Organ transplant patients are told not to use aspirin* or ibuprofen for pain relief but to use Tylenol (acetaminophen) as a safer alternative. If used properly Tylenol is safe when used as directed but overdosing can cause serious problems such as sudden liver failure.
Acetominophen (Tylenol®) can be taken safely if the daily dose does not exceed three grams (3,000 mg), or 6 extra strength tablets, in a 24 hour period.
It is important to read the labels on medications to know the content and dosage prior to taking the medication.
It is important to avoid any medication that contains ibuprofen or naproxen because they can interact with anti-rejection medications and cause kidney failure. Those medicines can also cause stomach ulcers and dangerous gastrointestinal bleeding. Examples that contain ibuprofen or naproxen and should be avoided include Advil®, Motrin®, Naprosyn® or Aleve.
*Aspirin-based drugs which contain salicylic acid, should also be avoided unless prescribed by a physician. Many times baby aspirin is prescribed to prevent heart attacks and is usually safe.
New Tylenol labeling unveiled
Acetominophen (Tylenol®) can be taken safely if the daily dose does not exceed three grams (3,000 mg), or 6 extra strength tablets, in a 24 hour period.
It is important to read the labels on medications to know the content and dosage prior to taking the medication.
It is important to avoid any medication that contains ibuprofen or naproxen because they can interact with anti-rejection medications and cause kidney failure. Those medicines can also cause stomach ulcers and dangerous gastrointestinal bleeding. Examples that contain ibuprofen or naproxen and should be avoided include Advil®, Motrin®, Naprosyn® or Aleve.
*Aspirin-based drugs which contain salicylic acid, should also be avoided unless prescribed by a physician. Many times baby aspirin is prescribed to prevent heart attacks and is usually safe.
New Tylenol labeling unveiled
“You Have the Power to Donate Life – Sign-up today! Tell Your Loved Ones of Your Decision”
No comments:
Post a Comment